|
|
|
|
| LEADER |
01318cam a2200349 a 4500 |
| 001 |
c000396610 |
| 003 |
CARM |
| 005 |
20140314105655.0 |
| 008 |
140314s1993 enka b 001 0 eng d |
| 010 |
|
|
|a 92049872
|
| 019 |
1 |
|
|a 9221386
|5 LACONCORD2021
|
| 020 |
|
|
|a 0632034416 (hbk.)
|
| 035 |
|
|
|a (OCoLC)26312083
|5 LACONCORD2021
|
| 040 |
|
|
|a LC
|b eng
|c LC
|d LC
|
| 050 |
0 |
0 |
|a RC271.C5
|b C29 1993
|
| 060 |
|
0 |
|a QZ267 C2146
|
| 082 |
0 |
4 |
|a 616.994061
|2 20
|
| 245 |
0 |
0 |
|a Cancer chemotherapy /
|c edited by John A. Hickman, Thomas R. Tritton.
|
| 260 |
|
|
|a Oxford ;
|a Boston :
|b Blackwell Scientific Publications,
|c 1993.
|
| 300 |
|
|
|a xiii, 369 p. :
|b ill. ;
|c 24 cm.
|
| 490 |
1 |
|
|a Frontiers in pharmacology & therapeutics
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
| 650 |
|
0 |
|a Antineoplastic agents
|x Mechanism of action.
|
| 700 |
1 |
|
|a Tritton, Thomas R.
|
| 700 |
1 |
|
|a Hickman, John A.
|
| 852 |
8 |
|
|b CARM
|p 0601398
|f BK
|
| 852 |
8 |
|
|b SCAN
|h A3:AE35B0
|i B12264
|p 0601398
|f BK
|
| 830 |
|
0 |
|a Frontiers in pharmacology & therapeutics
|
| 999 |
f |
f |
|i 4ae50553-6216-5b31-9d2c-09bb7634779b
|s d63baaf6-a1a9-5f1f-8c49-54c39cc43fe3
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|i book
|m 0601398
|
| 952 |
f |
f |
|a CAVAL
|b CAVAL
|c CAVAL
|d Unmapped Location
|e B12264
|f A3:AE35B0
|h Other scheme
|